Radboudumc
You will work in the Immunotherapy research group of the
Laboratory of Hematology, Department of Laboratory Medicine, Radboudumc, Nijmegen, the Netherlands. We focus on the characterization and modulation of anti-tumor immune responses in cancer patients.
Our translational research program encompasses four intermingled themes: 1) development of novel strategies to boost antitumor immunity after allogeneic stem cell transplantation, 2) co-signaling pathways involved in tumor immune escape, 3) DC-based vaccination strategies against hematological cancers, and 4) T and NK cell-based immunotherapy against leukemia, multiple myeloma and ovarian cancer. Our research is embedded in the Radboud Research Institute.
The studies indicated in this vacancy will be performed in close collaboration with clinicians of the Department of Hematology at the Radboudumc and the Prinses Máxima Center. We provide a stimulating work environment within a group of enthusiastic non-clinical and clinical researchers with a strong national and international research network and track record.
Radboudumc Radboud university medical center is a university medical center for patient care, scientific research, and education in Nijmegen. Radboud university medical center strives to be at the forefront of shaping the healthcare of the future. We do this in a person-centered and innovative way, and in close collaboration with our network. We want to have
a significant impact on health and healthcare. We want to improve with each passing day, continuously working towards better healthcare, research, and education. And gaining a better understanding of how diseases arise and how we can prevent, treat, and cure them, day in and day out. This way, every patient always receives the best healthcare, now and in the future. Because that is why we do what we do.